HSR&D Citation Abstract
Search | Search by Center | Search by Source | Keywords in Title
The Future of Patient Engagement in the Oncology Setting: How Practical Patient Engagement Recommendations and Innovative Inter-Professional Education Can Drive Change
Bosworth HB, Pini TM, Walters CB, Sih-Meynier R. The Future of Patient Engagement in the Oncology Setting: How Practical Patient Engagement Recommendations and Innovative Inter-Professional Education Can Drive Change. Journal of participatory medicine. 2017 Apr 11; 9(e.7):http://www.jopm.org.
Summary: Patient engagement is a National Quality Strategy priority and is especially pertinent to oncology care, since cancer treatment can be complex and involves shared decision making between patients and different health care providers. However, patient engagement remains inconsistently and ineffectively implemented. We convened a round-table discussion with stakeholders and experts in patient engagement to address innovative, practical recommendations for patient engagement in oncology. We highlight emerging ways that provider and patient education can be delivered to support patient engagement, as well as research opportunities associated with engagement in oncology.
Keywords: Oncology, patient engagement, reimbursement, policy, shared decision making, learning health system.
Citation: Bosworth HB, Pini TM, Walters CB, Sih-Meynier R. The future of patient engagement in the oncology setting: how practical patient engagement recommendations and innovative inter-professional education can drive change. J Participat Med. 2017 Apr 11; 9:e7.
Published: April 11, 2017.
Competing Interests: Dr. Bosworth has received grant funding from Sanofi, Takeda, Improved Patient Outcomes that went to Duke University to cover costs of his research team to conduct research. Dr. Bosworth also received consulting funds from Sanofi, Regeneron Pharmaceuticals, CVS, Blue Cross/Blue Shield of Arkansas, and Walgreens. Dr. Sih-Meynier is an employee at Genentech, Inc, and owns stock options. Dr. Pini is an employee of Premier, Inc, and owns stock options. Drs. Bosworth, Pini, and Burrows Walters received an honorarium from Genentech to participate in the roundtable that was used to generate ideas contained in the manuscript. The views expressed in this article are those of the author(s) and do not necessarily represent the position or policy of Duke University, the US Department of Veterans Affairs, or the US government.
Funding Sources: This project was funded by the Learning and Clinical Integration group within US Medical Affairs, Genentech, Inc. Dr. Bosworth was supported by a research career scientist award from VA Health Service Research and Development (VA HSRandD 08-027). Alexandra Howson MA, PhD, CHCP of Thistle Editorial, LLC, who was paid by Genentech, assisted in drafting and editing the manuscript. All authors confirm they have contributed to and reviewed the manuscript.